Mergers and Acquisitions

Marathon Oil agreed to sell its Norwegian assets to Det Norske Oljeselskap in a $2.7 billion deal, as the energy firm continues to strengthen its focus on U.S. production.

Valeant Pharmaceuticals said it would hike its cash-and-stock offer to buy Botox-maker Allergan -- a move that's backed by Pershing Square's Bill Ackman.

Tyson Foods entered into the race to acquire Hillshire Brands, launching a cash bid of $6.8 billion for the maker of Ball Park hot dogs and Jimmy Dean sausage.

Apple inked a deal on Wednesday to buy Beats Music and Beats Electronics, the music streaming and hardware businesses operated by Dr. Dre, for $3 billion. Why Apple Trimmed its Offer for Beats Music

Valeant sweetened its takeover bid for Botox maker Allergan, offering to buy the company for $49.4 billion.

Flint Hills Resources, a subsidiary of Koch Industries, agreed to buy PetroLogistics for $2.1 billion in cash, expanding its chemicals business.

Chicken producer Pilgrim’s Pride offered to acquire Hillshire Brands for $6.4 billion, potentially throwing a wrench into Hillshire’s plans to buy Pinnacle Foods.

AstraZeneca shares slumped Tuesday after Pfizer said it would not make a formal bid to acquire its smaller British rival.

Hess agreed to sell its gas stations and convenience stores to Marathon Petroleum's Speedway for $2.6 billion, as the energy producer turns its attention to drilling.

Google is buying Divide, a startup that helps businesses manage their employees’ mobile devices, as it looks to ramp up its Android division. 

Johnson Controls plans to spin off its auto-interiors business into a joint venture with a Chinese partner, as the diversified manufacturer shifts its focus to other units.

AstraZeneca rejected Pfizer’s final takeover offer on Monday, saying it still undervalues the drug giant. 

Darden Restaurants agreed to sell its Red Lobster chain to private equity firm Golden Gate Capital for $2.1 billion, as the restaurant operator pushes forward with plans to reshape its portfolio.

AstraZeneca's chief executive said his company's board would consider a compelling offer from Pfizer, despite turning down previous offers from the firm.

Valeant plans to unveil an improved offer for Botox maker Allergan later this month, as the Canadian drug company seeks to rally shareholder support for a buyout.

AT&T could seal a deal to acquire satellite television company DirecTV in the next two weeks, according to a report in The Wall Street Journal.

Mondelez agreed to merge its coffee business with D.E. Master Blenders, forming a new company that can better compete with Nestle and allowing Mondelez to focus on its snack portfolio.

Freeport-McMoRan Copper & Gold will sell its Eagle Ford Shale assets to Canada's Encana for $3.1 billion.

Merck agreed to sell its consumer-care unit to German pharmaceutical giant Bayer for $14.2 billion, continuing a flurry of healthcare deals.

AstraZeneca turned down a sweetened buyout offer of $106.4 billion from rival drug giant Pfizer, thwarting a move that would have created the world’s largest pharmaceutical company.